ROME — In this Healio Video Perspective from the FLORetina-ICOOR meeting, Aleksandra Rachitskaya, MD, gives a broad overview of geographic atrophy management in the clinic now that treatments have become available.
One of the challenges comes from the fact that patients recruited in clinical trials do not represent the whole spectrum of patients in clinical practice, and it is hard to decide how to apply safety and efficacy data. In addition, geographic atrophy (GA) is probably underestimated in terms of numbers because GA is undercoded, as shown by many studies.
She also speaks about the